Terms: = Endocrine gland cancer AND ATIC, IMPCHASE, 471, ENSG00000138363, AICARFT, P31939, PURH AND Treatment
56 results:
1. Serum anti-Müllerian hormone is lower in patients with multiple radioiodine dose for treatment of pediatric thyroid cancer.
Barreto MCA; Treistman N; Cavalcante LBCP; Bulzico D; de Andrade FA; Corbo R; Alves Junior PAG; Vaisman F
Eur Thyroid J; 2024 Apr; 13(2):. PubMed ID: 38290210
[TBL] [Abstract] [Full Text] [Related]
2. Circulating small extracellular vesicles microRNAs plus CA-125 for treatment stratification in advanced ovarian cancer.
Zhou X; Liu M; Sun L; Cao Y; Tan S; Luo G; Liu T; Yao Y; Xiao W; Wan Z; Tang J
J Transl Med; 2023 Dec; 21(1):927. PubMed ID: 38129848
[TBL] [Abstract] [Full Text] [Related]
3. Association between county-level socioeconomic status and the incidence of and surgical treatment for pituitary adenoma.
Cote DJ; Kruchko C; Barnholtz-Sloan JS; Zada G; Wiemels JL; Ostrom QT
J Neurosurg; 2024 Mar; 140(3):724-734. PubMed ID: 37877990
[TBL] [Abstract] [Full Text] [Related]
4. Prognosis of pancreaticoduodenectomy in octogenarians for pancreatic ductal adenocarcinoma with propensity score matched analysis.
Jeong H; Lim SY; Jeon HJ; Yoon SJ; Kim H; Han IW; Heo JS; Shin SH
ANZ J Surg; 2023 Nov; 93(11):2655-2663. PubMed ID: 37658597
[TBL] [Abstract] [Full Text] [Related]
5. Bilaterality, not multifocality, is an independent risk factor for recurrence in low-risk papillary thyroid cancer.
Rodriguez Schaap PM; Lin JF; Metman MJH; Dreijerink KMA; Links TP; Bonjer HJ; Nieveen van Dijkum EJM; Dickhoff C; Kruijff S; Engelsman AF
J Natl Cancer Inst; 2023 Sep; 115(9):1071-1076. PubMed ID: 37267155
[TBL] [Abstract] [Full Text] [Related]
6. FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational study.
Kobayashi S; Tezuka S; Yamachika Y; Tsunoda S; Nagashima S; Tozuka Y; Fukushima T; Morimoto M; Ueno M; Furuse J; Maeda S
BMC Cancer; 2023 Feb; 23(1):177. PubMed ID: 36809997
[TBL] [Abstract] [Full Text] [Related]
7. Long-term Outcomes of Ultrasound-guided Thermal Ablation for the treatment of Solitary Low-risk Papillary Thyroid Microcarcinoma: A Multicenter Retrospective Study.
Yan L; Liu Y; Li W; Zhu Y; Wang J; Zhang M; Tang J; Che Y; Wang H; Wang S; Luo Y
Ann Surg; 2023 May; 277(5):846-853. PubMed ID: 36727947
[TBL] [Abstract] [Full Text] [Related]
8. Association between thyroid cancer and cardiovascular disease risk: a nationwide observation study.
Tsai MC; Hsieh CT; Hsu HY; Yeh TL; Lee WC; Chiang CJ; Hsiao BY; Jhuang JR; Tsai WH; Cheng SP; Chou CL; Lee CC; Liu SC; Tseng PJ; Chien KL
Sci Rep; 2022 Nov; 12(1):18438. PubMed ID: 36323730
[TBL] [Abstract] [Full Text] [Related]
9. Sequential therapy for pancreatic cancer patients with synchronous oligo-hepatic metastatic lesions.
Lu W; Wang L; Lou J; Tang K
Tumori; 2023 Jun; 109(3):307-313. PubMed ID: 35815545
[TBL] [Abstract] [Full Text] [Related]
10. [Minimally invasive enucleation for benign and low-grade malignant pancreatic tumors: an analysis of 60 cases].
Liu MQ; Liu WS; Li Z; Zhuo QF; Ji SR; Xu WY; Shi YH; Yu XJ; Xu XW
Zhonghua Wai Ke Za Zhi; 2022 Jul; 60(7):674-679. PubMed ID: 35775260
[No Abstract] [Full Text] [Related]
11. A study on the antitumor effect of gemcitabine polybutylcy- anoacrylate nanoparticles coupled with Mucin 1 monoclonal antibody on pancreatic cancer
Zhang L; Zhu J; Hou Y; Li C; Liu H
J Cancer Res Ther; 2021 Dec; 17(7):1702-1708. PubMed ID: 35381742
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma.
Waguespack SG; Drilon A; Lin JJ; Brose MS; McDermott R; Almubarak M; Bauman J; Casanova M; Krishnamurthy A; Kummar S; Leyvraz S; Oh DY; Park K; Sohal D; Sherman E; Norenberg R; Silvertown JD; Brega N; Hong DS; Cabanillas ME
Eur J Endocrinol; 2022 Apr; 186(6):631-643. PubMed ID: 35333737
[TBL] [Abstract] [Full Text] [Related]
13. Peritoneal carcinosis in male germ cell tumor patients: a registry study compiled by the German Testicular cancer Study Group (GTCSG).
Seidel C; Hentrich M; Zschäbitz S; Paffenholz P; Heidenreich A; Nestler T; Tran B; Fischer S; Daugaard G; Ochsenreither S; Brito M; Zengerling F; Schwab C; Bokemeyer C; Oing C
World J Urol; 2022 Feb; 40(2):355-361. PubMed ID: 34993564
[TBL] [Abstract] [Full Text] [Related]
14. Overview of PROTACs Targeting the Estrogen Receptor: Achievements for Biological and Drug Discovery.
Qin H; Zhang Y; Lou Y; Pan Z; Song F; Liu Y; Xu T; Zheng X; Hu X; Huang P
Curr Med Chem; 2022; 29(22):3922-3944. PubMed ID: 34758713
[TBL] [Abstract] [Full Text] [Related]
15. Molecular and clinical predictors of improvement in progression-free survival with maintenance PARP inhibitor therapy in women with platinum-sensitive, recurrent ovarian cancer: A meta-analysis.
Lee CK; Friedlander ML; Tjokrowidjaja A; Ledermann JA; Coleman RL; Mirza MR; Matulonis UA; Pujade-Lauraine E; Bloomfield R; Goble S; Wang P; Glasspool RM; Scott CL;
Cancer; 2021 Jul; 127(14):2432-2441. PubMed ID: 33740262
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic relevance of longitudinal HGF levels in serum of patients with ovarian cancer.
Klotz DM; Link T; Wimberger P; Kuhlmann JD
Mol Oncol; 2021 Dec; 15(12):3626-3638. PubMed ID: 33738970
[TBL] [Abstract] [Full Text] [Related]
17. [Measurement of PODXL and SCGB1D2 for detecting intraductal papillary mucinous neoplasm].
Taniuchi K; Okabayashi T; Sakaguchi M; Iwata J
Nihon Shokakibyo Gakkai Zasshi; 2021; 118(3):235-244. PubMed ID: 33692257
[TBL] [Abstract] [Full Text] [Related]
18. Feasibility of
Bunyaeva E; Kirillova A; Khabas G; Asaturova A; Mishieva N; Nazarenko T; Abubakirov A; Sukhikh G
Int J Gynecol Cancer; 2021 Mar; 31(3):475-479. PubMed ID: 33649016
[TBL] [Abstract] [Full Text] [Related]
19. Microwave ablation of autonomously functioning thyroid nodules: a comparative study with radioactive iodine therapy on the functional treatment success.
Ertürk MS; Cekic B; Celik M; Demiray Uguz I
Endokrynol Pol; 2021; 72(2):120-125. PubMed ID: 33619707
[TBL] [Abstract] [Full Text] [Related]
20. Margin Positivity and Survival Outcomes: A Review of 14,471 Patients with 1-cm to 4-cm Papillary Thyroid Carcinoma.
Khan ZF; Kutlu O; Picado O; Lew JI
J Am Coll Surg; 2021 Apr; 232(4):545-550. PubMed ID: 33421566
[TBL] [Abstract] [Full Text] [Related]
[Next]
